Expired Tender Slovakia ICB TOT Ref. 65712414

Human Fibrinogen and Human Prothrombin Complex Tender - 65712414

Tender notice from Slovakia, published on 23 Apr 2022.

Executive Summary

The CENTRAL DEPARTMENT OF HEART AND VASCULAR DISEASES, A.S. has issued a Tender notice for the procurement of a Human Fibrinogen and Human Prothrombin Complex in the Slovakia. This Tender notice was published on 23 Apr 2022 and is scheduled to close on 09 May 2022, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 65712414, while the tender notice number is 212361-2022 and Register on the platform.

Key facts

Summary
Human Fibrinogen and Human Prothrombin Complex
TOT Ref. No.
65712414
Document Ref. No.
212361-2022
Country
Slovakia
Notice type
Tender
Competition
ICB
Publication date
23 Apr 2022
Bid deadline
09 May 2022
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Document Type: Corrigendum / Additional Information (PLEASE REFER Tender Document)
Title: Human fibrinogen and human prothrombin complex
Reference Number: SUSCCH-NZ-VS-20122-Lud.-Finogen-Lud.-Protombin.-Complex
Contract Type: Supplies
Description: The subject of the contract is the supply of medicines for the contracting authority - human fibrinogen and the human prothrombin complex
- in accordance with Annex no. 4 competition documents.
The order consists of two separate parts - medicines with the quantitative and qualitative composition of the medicine,
Medicinal form, method of administration and size of packaging, with delivery to the destination in accordance with the needs and requirements
The contracting authority listed in Annex no. 3 competition documents. The drug offered must be found in the registration database of medicines kept by the State Institute for Drug Control.
More detailed information about the subject of the contract is listed in the tender documents.
33621200 - Antihaemorrhagics
Authority Type: Body Governed by Public Law
Type of procedure: Open Procedure
Regulation: European Union, with Participation by GPA Countries
Bid Type: Submission For All Lots
DOC TITLE: Antihae ...

Documents

Tender Notice
Login to view

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Electrodeless Stimulation System for Transcatheter Implantation Slovakia 152601116 20 Nov 2026
Medicines for the Respiratory System Slovakia 152592604 17 Dec 2026
Hygienic and Cleaning Products Slovakia 152592423 25 Nov 2026
Robotic Surgery Center for the Faculty of Medicine of the Comenius University Slovakia 152587318 01 Dec 2026
Intervention Accessories: Injector of Contrast Agent for Ct Slovakia 152580359 15 Dec 2026

Slovakia Public Procurement Intelligence

Frequently asked questions

The bid deadline for Human Fibrinogen and Human Prothrombin Complex was 09 May 2022. Bidding is closed.

This tender has been issued by CENTRAL DEPARTMENT OF HEART AND VASCULAR DISEASES, A.S. in Slovakia.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33621200 - Antihaemorrhagics.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 65712414. The purchaser document reference is 212361-2022.

See the Similar Tenders section on this page or browse other tenders from Slovakia.

This tender falls under Materials and Products, Technology and Equipment in Slovakia. Suppliers in these sectors can track similar Slovakia tenders using CPV-based alerts.